Am­neal Phar­ma­ceu­ti­cals site in In­dia re­ceives 483 over clean­ing and oth­er qual­i­ty is­sues

A man­u­fac­tur­ing site that be­longs to Am­neal Phar­ma­ceu­ti­cals is un­der the FDA’s mi­cro­scope.

The site in ques­tion is a par­enter­al, or in­jectable, man­u­fac­tur­ing fa­cil­i­ty in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER